Connect with us

Health

Cardiovascular adverse events linked to hydroxychloroquine and chloroquine – News-Medical.Net

As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications.

Published

on

Reviewed by Emily Henderson, B.Sc.Sep 23 2020
As the antimalarial drugs, hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications. A recent analysis published in the British Journal of Clinical Pharmacology provides new insights.
In the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending